Category Archives: Regenerative Medicine

MIAMI (PRWEB) October 27, 2014

Global Stem Cells Group has announced the launch of the official Regenestem Network website, dedicated to promoting the worlds largest and most recognizable membership organization of regenerative medicine practitioners. The Regenestem Network was developed to promote the Miami-based companys global expansion program and establish affiliate representatives able to bring stem cell treatments, therapies, training courses and conferences to communities worldwide.

In order to become a part of the Regenestem Network, medical practitioners are required to have more than five years experience in the health care industry that includes experience in regenerative medicine. In return, network physicians are entitled to a myriad of benefits and advantages built into the Regenestem Network membership model, including:

Global Stem Cells Group Founder and CEO Benito Novas says that Regenestem Network members also enjoy royalty-free income by committing to the companys established protocols and proven system for the best patient outcomes. Additional benefits of the Regenestem Network membership model include:

Unlike a typical franchise agreement, if you decide to leave us someday we dont take your company away from you, Novas says. We build high quality partnerships with leading stem cell scientists and physicians around the world by establishing mutually beneficial relationships based on professional respect and collaboration.

For more information on the Regenestem Network, visit the Global Stem Cells Group website, email bnovas(at)stemcellsgroup(dot)com, or call 305-224-1858.

About the Global Stem Cells Group:

Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions. With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.

Global Stem Cells Groups corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCGs six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.

To learn more about Global Stem Cells Group, Inc.s companies and for investor information, visit the Global Stem Cells Group website, email bnovas(at)regenestem(dot)com, or call 305-224-1858.

Read this article:
Global Stem Cells Group Announces Launch of Official Regenestem Network Website

Osiris - Company Presentation
Presented by: Lode Debrabandere, Ph.D., CEO Through over 20 years of research, experience and understanding, Osiris Therapeutics has led the way in mesenchymal stem cell (MSC) science and ...

By: Alliance for Regenerative Medicine

See more here:
Osiris - Company Presentation - Video

MIAMI (PRWEB) October 22, 2014

More than 900 physicians researchers and regenerative medicine experts from around the world attended the First International Symposium on Stem Cells and Regenerative Medicine, held in Buenos Aires, Argentina Oct. 2-4, 2014.

The event, hosted by Global Stem Cells Group in partnership with Julio Ferreira, M.D., President of the South American Academy Cosmetic Surgery, offered an opportunity for many of the worlds most respected authorities on stem cell and regenerative medicine to showcase advancements in research and therapies on a global level.

An interdisciplinary team of leading international stem cell experts provided a full day of high-level scientific lectures geared to medical professionals. Pioneers and luminaries in stem cell medicine who served as featured speakers at the event included:

Lord David Harrell, PhD., a scientific leader recognized nationally, internationally recognized expert in neuroscience and regenerative medicine and a member of the Global Stem Cells Group Advisory Board spoke on spoke on the cellular composition of bone marrow with a focus on stem and progenitor cell activities of bone marrow stem and progenitor cells.

Joseph Purita, M.D., Director of The Institute of Regenerative and Molecular Orthopedics in Boca Raton, Florida, member of the Global Stem Cells Group Advisory Board and a pioneer in the use of stem cells and platelet rich plasma for a variety of orthopedic conditions, spoke about the use of PRP and stem cell injections for treatment of musculoskeletal conditions. He detailed cutting-edge treatments he now offers to his clinic patients, including extensive use of platelet-rich plasma in conjunction with bone marrow stem cells (BMAC), adipose stem cells (SVF) and fat grafts.

Vasilis Paspaliaris, M.D., CEO of Adistem, Ltd., a member of the Global Stem Cells Group Advisory Board and a thought-leading and highly experienced clinical pharmacologist and medical scientist discussed the proven differences in efficacy between the mesenchyme stem cells (MSCs) of a young donor and those of an aging donor, primarily due to the younger donor cells ability to secrete more trophic factors.

According to Benito Novas, Global Stem Cells Group CEO, the world-class event was well received at a time when the field of regenerative medicine is on the verge of changing medical science forever.

We wanted the symposium to help clear up old misconceptions and change outdated attitudes by educating people on the wide range of illnesses and injuries stem cell therapies are already treating and curing, Novas says. We set out to establish a dialogue between researchers and practitioners in order to help move stem cell therapies from the lab to the physicians office and I believe we achieved our goals with this symposium.

Our objective is to open a dialogue among the worlds medical and scientific communities in order to advance stem cell technologies and translate them into point-of-care medical practices.

Continued here:
More than 900 Physicians Converge on Buenos Aires for Global Stem Cells Groups First International Symposium on Stem ...

Overview of Regenerative Medicine Partnering Merger Acquisition Market
The report provides a detailed understanding and analysis of how and why companies enter regenerative medicine and stem cells partnering deals. The majority ...

By: John Brown

The rest is here:
Overview of Regenerative Medicine Partnering Merger & Acquisition Market - Video

Dr. Deepak Srivastava, a leading biomedical research policy expert, will discuss "Stem Cells, Regenerative Medicine and Policy Impediments to the New Future" at Rice University's Baker Institute for Public Policy Oct. 21. The event is free and open to the public, but registration is required.

Who: Dr. Deepak Srivastava, the Baker Institute's nonresident scholar for biomedical research policy and the Younger Family Director and senior investigator at the Gladstone Institute of Cardiovascular Disease.

Neal Lane, the Malcolm Gillis University Professor, senior fellow in science and technology policy at Rice's Baker Institute for Public Policy and a professor of physics and astronomy, will give introductory remarks.

What: A presentation titled "Stem Cells, Regenerative Medicine and Policy Impediments to the New Future."

When: Tuesday, Oct. 21, 7:45-9:30 a.m. Breakfast will be served at 7:45.

Where: Rice University, James A. Baker III Hall, Kelly International Conference Facility, 6100 Main St.

Stem cells and regenerative medicine are exciting and emerging fields of biomedical research, according to event organizers. Proposed applications include treating conditions such as blindness, diabetes and heart disease. Regenerative medicine could also help heal failing organ systems and replace damaged tissue. While these fields hold great promise for medicine, external factors limit and, in some cases, stall research, organizers said. Ethical controversies surrounding human embryonic stem cells, policy issues affecting federal and state funding and regulation, and economic pressures all play a role in determining the future of research.

In his presentation, Srivastava will explore the current and future potential of stem cells and regenerative medicine. Following the presentation, he will discuss policy challenges and opportunities with Lane.

The event is sponsored by the Baker Institute's Science and Technology Policy Program and the Health Policy Forum.

Read the original post:
Policy impediments to using stem cells and regenerative medicine to be discussed at Rice's Baker Institute Oct. 21

Tampa, FL (PRWEB) October 13, 2014

On Monday, October 20, Regenerative Medicine Solutions (RMS) is set to open its doors to two new clinics in Nashville, Tennessee. RMS welcomes the launch of an entirely new facility, the Sleep Apnea Institute, and the expansion of a new treatment center for the Lung Institute. The new centers will be marked by an official ribbon cutting ceremony from the medical staff, RMS corporate team, and members of the Nashville Chamber of Commerce.

With the introduction of the Sleep Apnea Institute to Nashville, the hope is to bring awareness to those individuals that suffer from sleep apnea: both diagnosed and undiagnosed. Currently, there are 22 million Americans that suffer from sleep apnea, with 80 percent being undiagnosed. The Sleep Apnea Institute treats patients through a specialized procedure known as radiofrequency ablation.

With Nashville being a hub for medical technology, this was a prime location to expand the Lung Institute brand. After the current success of treating 400 patients at the clinic in Tampa, FL., the new expansion will bring stem cell treatments and innovative medicine to the Nashville area. Using stem cells from the patients own body, the Lung Institute treats lung diseases including pulmonary fibrosis and chronic obstructive pulmonary disease (COPD), a progressive disease that causes difficulty breathing.

Jack Coleman, Jr, MD, is the medical director of the Sleep Apnea Institute and the Lung Institute in Nashville. He earned his medical degree from the University of Cincinnati as well as completed his internship and general surgery residency at the institution. Dr. Coleman is Board Certified in Otolaryngology and ensures that all treatments and staff will follow strict standards with the highest excellence in personalized patient care.

I am very excited about these new facilities opening, says Dr. Coleman. The Sleep Apnea Institute and the Lung Institute are providing innovative procedures for patients with debilitating conditions and will be a prime location for patients in Nashville.

Join us for the official ribbon cutting ceremony for the Sleep Apnea Institute and the Lung Institute, current Lung Institute patient will be available for questions:

When: Monday, October 20, 2014 at 10:00 a.m. Where: Sleep Apnea Institute & Lung Institute, 2001 Mallory Lane, Suite 302, Franklin, TN 37067

About Regenerative Medicine Solutions Regenerative Medicine Solutions (RMS) is a leading global provider of innovative regenerative technologies that treat an array of debilitating medical conditions. In addition, the company is the owner and operator of the Sleep Apnea Institute and the Lung Institute. Committed to an individualized patient-centric approach, RMS consistently provides the highest quality of care while producing positive outcomes. By applying modern-day best practices to the growing field of regenerative medicine, RMS is changing lives. For more information, visit our website at myregenmed.com, like us on Facebook, or follow us on Twitter or call us today at 1-877-867-4551.

###

See the original post here:
Regenerative Medicine Solutions Establishes Two New Clinics

Tampa, FL (PRWEB) September 30, 2014

Regenerative Medicine Solutions (RMS) is set to open its doors to two new clinics in Nashville, Tennessee. RMS welcomes the launch of an entirely new facility, the Sleep Apnea Institute, and the expansion of a new treatment center for the Lung Institute.

With the introduction of the Sleep Apnea Institute to Nashville, the hope is to bring awareness to those individuals that suffer from sleep apnea: both diagnosed and undiagnosed. With Nashville being a hub for medical technology, this was a prime location to expand the Lung Institute brand. After the current success of treating 400 patients at the clinic in Tampa, FL., the new expansion will bring stem cell treatments and innovative medicine to the Nashville area.

Jack Coleman, Jr, MD, will be the medical director of the Sleep Apnea Institute and the Lung Institute in Nashville. He holds a medical degree from the University of Cincinnati as well as completed his internship and general surgery residency at the institution. In all, Dr. Coleman has been practicing medicine for over 40 years.

I am very excited about these new facilities opening, says Dr. Coleman. The Sleep Apnea Institute and the Lung Institute are providing innovative procedures for patients with debilitating conditions and will be a prime location for patients in Nashville.

About Regenerative Medicine Solutions Regenerative Medicine Solutions (RMS) is a leading global provider of innovative regenerative technologies that treat an array of debilitating medical conditions. In addition, the company is the owner and operator of the Sleep Apnea Institute and the Lung Institute. Committed to an individualized patient-centric approach, RMS consistently provides the highest quality of care while producing positive outcomes. By applying modern-day best practices to the growing field of regenerative medicine, RMS is changing lives. For more information, visit our website at myregenmed.com, like us on Facebook, or follow us on Twitter or call us today at 1-877-867-4551.

See the article here:
Regenerative Medicine Solutions Expanding

PUBLIC RELEASE DATE:

25-Sep-2014

Contact: Sandy Van sandy@prpacific.com 808-526-1708 Cedars-Sinai Medical Center @cedarssinai

LOS ANGELES (Sept. 25, 2014) Investigators at the Cedars-Sinai Board of Governors Regenerative Medicine Institute have received a grant from the National Institutes of Health to participate in a consortium taking the study of motor neuron disorders such as Lou Gehrig's disease and spinal muscular atrophy to a new, comprehensive perspective.

"We will be working as part of an NIH initiative to create databases of disease 'signatures' by generating and analyzing thousands of data points. Scientists often focus on very small things, such as a single signaling pathway in cells or a single gene or protein that is involved in some way with disease development, but identifying and correcting one component rarely leads to a cure. This is especially true in the brain because its networks are very complex," said Clive Svendsen, PhD, professor and director of the Board of Governors Regenerative Medicine Institute, principal investigator of Cedars-Sinai's part of the study.

Svendsen, the Kerry and Simone Vickar Family Foundation Distinguished Chair in Regenerative Medicine, compares this shift in perspective to the way meteorologists began predicting weather years ago viewing global trends and collecting vast amounts of data to create a forecast for a specific place and time.

The grant is part of an NIH initiative called the Library of Integrated Network-based Cellular Signatures, or LINCS, program, which aims to develop a "library" of molecular signatures that describes how different cells respond to proteins, genes, chemicals essentially anything that may come in contact with or change the cell or its activity.

Cedars-Sinai is a member of a group, NeuroLINCS, studying motor neuron disorders, which include Lou Gehrig's disease, also known as amyotrophic lateral sclerosis, or ALS, and spinal muscular atrophy. The NeuroLINCS study will be coordinated by researchers at the University of California, Irvine, with additional collaborators at the Gladstone Institutes at the University of California, San Francisco, Johns Hopkins University and the Broad Institute.

NeuroLINCS is one of six consortiums recently funded through NIH's LINCS program to study diabetes, cancers and other diseases using cell lines and specialized stem cells called induced pluripotent stem cells. Derived from a patient's own skin samples and "sent back in time" through genetic manipulation to an embryonic state, these cells can be made into any cell of the human body.

The Board of Governors Regenerative Medicine Institute, which has developed a national reputation for the quality of its induced pluripotent stem cells, was asked to provide the stem cells for all of the consortiums. The cells are produced in the Regenerative Medicine Institute's Induced Pluripotent Stem Cell Core Facility, directed by Dhruv Sareen, PhD, assistant professor of biomedical sciences and faculty research scientist with the Department of Biomedical Sciences.

See the original post here:
With NIH grant, Cedars-Sinai helps bring big data to neuro disease research

Queenstown could become an international mecca for regenerative medicine, with a Chinese delegation in the resort to negotiate opening a $10 million to $20m medical complex.

The delegation included businessman Xia Jie, owner of the largest chain of diagnostic and wellness clinics across China, who has been meeting the Queenstown Lakes District Council, developers, Queenstown Chamber of Commerce and Destination Queenstown as part of a four-day "fact-finding mission".

Proposed sites for the medicine and medical research centre have been investigated at Remarkables Park, Five Mile and Jack's Point.

Xia's company operates the Health 100 brand, with more than 7 million patients so far this year.

If given the green light, the centre could attract up to 10,000 international clients from China and across the globe annually.

United States-based reproductive endocrinologist, sexual and regenerative medical specialist Dr Sam Wood and stem-cell expert Professor Richard Boyd, of Melbourne's Monash University, were part of the delegation.

The proposed world-class centre could make Queenstown an important hub for regenerative medicine, Wood said.

Queenstown was being looked at because of it world-class tourism status, established "four seasons" appeal and the recreational activities on offer.

People who wanted high-end treatment wanted to go to nice places and it was common for people in the US to travel to Aspen, Colorado, Wood said.

He was hoping to introduce to Queenstown procedures he helped develop in the US, such as vampire facelifts, breast lifts and flagship "M" and "O" shots to aid male and female sexual dysfunction. As well as being a research facility, the centre would be a mecca for high-profile athletes needing rehabilitation, low-level surgeries and imaging services. It was also hoped to expand stem-cell therapy on offer in the area.

Here is the original post:
Queenstown eyed as 'medical mecca'

Inflammatory Bowel Disease (IBD) Stem Cell Research: Ophir Klein, UCSF
In his presentation to the California Stem Cell Agency (CIRM) governing Board, Dr. Ophir Klein, a CIRM grantee and UCSF researcher, detailed his lab #39;s work to understand how stem cells regulate...

By: California Institute for Regenerative Medicine

View original post here:
Inflammatory Bowel Disease (IBD) & Stem Cell Research: Ophir Klein, UCSF - Video